<table id="_Refid_f2e24f56-58d0-4cb8-8cbc-cfed7956c" width="100%" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption>Table 1: Select Mean (± SD) Metformin Pharmacokinetic Parameters Following Single or Multiple Oral Doses of Metformin</caption>
<col width="45%"></col>
<col width="16%"></col>
<col width="16%"></col>
<col width="22%"></col>
<tbody>
<tr>
<td align="center" stylecode="Rrule Botrule Lrule Toprule ">
<paragraph>
<content stylecode="bold">Subject Groups: Metformin</content>
</paragraph>
<paragraph>
<content stylecode="bold">Dose</content>
<footnote id="_Refid-66e61818-5fdd-456f-ac33-21c32045a">All doses given fasting except the first 18 doses of the multiple-dose studies</footnote>
<content stylecode="bold"> (Number of Subjects)</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Toprule ">
<paragraph>
<content stylecode="bold">C<sub>max </sub>
</content>
<footnote id="_Refid-9a8fa7ff-0ba4-4771-b7e5-3a853971c">Peak plasma concentration</footnote>
</paragraph>
<paragraph>
<content stylecode="bold">(mcg/mL)</content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Toprule ">
<paragraph>
<content stylecode="bold">T<sub>max </sub>
</content>
<footnote id="_Refid-20dd0184-c09d-4e4b-ae3b-3f603dd2e">Time to peak plasma concentration</footnote>
</paragraph>
<paragraph>
<content stylecode="bold">(hrs) </content>
</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule Toprule ">
<paragraph>
<content stylecode="bold">Renal Clearance</content>
</paragraph>
<paragraph>
<content stylecode="bold">(mL/min)</content>
</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="bold">Healthy, Nondiabetic Adults: </content>
</paragraph>
<paragraph>  500 mg SD<footnote id="_Refid-816cc8c3-c58f-4f4e-84af-3c29aee8b">SD = single dose</footnote> (24)</paragraph>
<paragraph>  850 mg SD (74)<footnote id="_Refid-18234f61-7a97-491c-bc05-63e9cd736">Combined results (average means) of five studies: mean age 32 years (range 23 to 59 years)</footnote>
</paragraph>
<paragraph>  850 mg t.i.d. for 19 doses<footnote id="_Refid-4987955d-fdc6-42c9-8f9f-eb4fa3f43">Kinetic study done following dose 19, given fasting</footnote> (9)</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule ">
<paragraph>1.03 (± 0.33)</paragraph>
<paragraph>1.60 (± 0.38)</paragraph>
<paragraph>2.01 (± 0.42)</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule ">
<paragraph>2.75 (± 0.81)</paragraph>
<paragraph>2.64 (± 0.82)</paragraph>
<paragraph>1.79 (± 0.94)</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule ">
<paragraph>600 (± 132)</paragraph>
<paragraph>552 (± 139)</paragraph>
<paragraph>642 (± 173)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="bold">Adults with Type 2 Diabetes:</content>
</paragraph>
<paragraph>  850 mg SD (23)</paragraph>
<paragraph>  850 mg t.i.d. for 19 doses<footnoteref idref="_Refid-4987955d-fdc6-42c9-8f9f-eb4fa3f43"></footnoteref> (9)</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule ">
<paragraph>1.48 (± 0.5)</paragraph>
<paragraph>1.90 (± 0.62)</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule ">
<paragraph>3.32 (± 1.08)</paragraph>
<paragraph>2.01 (± 1.22)</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule ">
<paragraph>491 (± 138)</paragraph>
<paragraph>550 (± 160)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Lrule Botrule ">
<paragraph>
<content stylecode="bold">Elderly </content>
<footnote id="_Refid-49b06b68-8850-413b-a601-f0d7e3770">Elderly subjects, mean age 71 years (range 65 to 81 years)</footnote>
<content stylecode="bold">, Healthy Nondiabetic </content>
</paragraph>
<paragraph>
<content stylecode="bold">Adults:</content>
</paragraph>
<paragraph>  850 mg SD (12)</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule ">
<paragraph>2.45 (± 0.70)</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule ">
<paragraph>2.71 (± 1.05)</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule ">
<paragraph>412 (± 98)</paragraph>
</td>
</tr>
<tr>
<td stylecode="Rrule Botrule Lrule ">
<paragraph>
<content stylecode="bold">Renal-impaired Adults: 850 mg SD</content>
</paragraph>
<paragraph>  Mild (CLcr <footnote id="_Refid-0ee0a954-50f6-44e4-bf96-a6fdf072e">CL<sub>cr</sub> = creatinine clearance normalized to body surface area of 1.73 m<sup>2</sup>
</footnote> 61 to 90 mL/min) (5)</paragraph>
<paragraph>  Moderate (CL<sub>cr </sub>31 to 60 mL/min) (4)</paragraph>
<paragraph>  Severe (CL<sub>cr </sub>10 to 30 mL/min) (6) </paragraph>
</td>
<td align="center" stylecode="Rrule Botrule ">
<paragraph>1.86 (± 0.52)</paragraph>
<paragraph>4.12 (± 1.83)</paragraph>
<paragraph>3.93 (± 0.92)</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule ">
<paragraph>3.20 (± 0.45)</paragraph>
<paragraph>3.75 (± 0.50)</paragraph>
<paragraph>4.01 (± 1.10)</paragraph>
</td>
<td align="center" stylecode="Rrule Botrule ">
<paragraph>384 (± 122)</paragraph>
<paragraph>108 (± 57)</paragraph>
<paragraph>130 (± 90)</paragraph>
</td>
</tr>
</tbody>
</table>